ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.695
      -0.11%
      Bitcoin
      65,044.63
      -0.14%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. KALA BIO Inc (KALA)

      7. KALA BIO Inc (KALA) News

      KALA

      KALA BIO (KALA)

      KALA BIO Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:KALA
      DateTimeSourceHeadlineSymbolCompany
      04/29/20208:51AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:KALAKALA BIO Inc
      04/17/20204:01PMBusiness WireKala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:KALAKALA BIO Inc
      04/13/20208:39AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KALAKALA BIO Inc
      04/08/20207:31AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KALAKALA BIO Inc
      04/03/20204:01PMBusiness WireKala Pharmaceuticals Announces Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:KALAKALA BIO Inc
      04/01/20204:43PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KALAKALA BIO Inc
      03/23/20205:01PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:KALAKALA BIO Inc
      03/17/20205:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KALAKALA BIO Inc
      03/13/20206:47PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KALAKALA BIO Inc
      03/13/20206:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KALAKALA BIO Inc
      03/13/20205:20PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:KALAKALA BIO Inc
      03/12/20206:06AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KALAKALA BIO Inc
      03/12/20206:04AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:KALAKALA BIO Inc
      03/11/20206:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KALAKALA BIO Inc
      03/11/20206:02AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:KALAKALA BIO Inc
      03/10/202011:02PMBusiness WireKala Pharmaceuticals Announces Pricing of Public Offering of 16,000,000 Shares of Common StockNASDAQ:KALAKALA BIO Inc
      03/10/20204:44PMBusiness WireKala Pharmaceuticals Announces Proposed Public Offering of Common StockNASDAQ:KALAKALA BIO Inc
      03/09/20206:07AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KALAKALA BIO Inc
      03/09/20206:00AMBusiness WireKala Pharmaceuticals Announces Statistically Significant Results for Primary & Key Secondary Endpoints in STRIDE 3 Clinical T...NASDAQ:KALAKALA BIO Inc
      02/20/20204:01PMBusiness WireKala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:KALAKALA BIO Inc
      02/13/20206:03AMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:KALAKALA BIO Inc
      02/12/20205:26PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:KALAKALA BIO Inc
      02/12/20204:55PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:KALAKALA BIO Inc
      02/12/20207:16AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KALAKALA BIO Inc
      02/12/20207:00AMBusiness WireKala Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial ResultsNASDAQ:KALAKALA BIO Inc
      02/06/20208:00AMBusiness WireKala Pharmaceuticals to Report Fourth Quarter and Full Year 2019 Financial Results and Host Conference CallNASDAQ:KALAKALA BIO Inc
      01/15/20208:00AMBusiness WireKala Pharmaceuticals Announces Completion of Enrollment of STRIDE 3 Trial for EYSUVIS™ (KPI-121 0.25%) for Dry Eye DiseaseNASDAQ:KALAKALA BIO Inc
      01/13/20207:31AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KALAKALA BIO Inc
      01/08/20208:00AMBusiness WireKala Pharmaceuticals to Present at 38th Annual J.P. Morgan Healthcare ConferenceNASDAQ:KALAKALA BIO Inc
      01/03/20204:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KALAKALA BIO Inc
       Showing the most relevant articles for your search:NASDAQ:KALA